Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prokineticin receptor 1 is a G protein-coupled receptor for prokineticins, small protein ligands involved in angiogenesis, inflammation, and reproductive biology. PROKR1 is primarily coupled to Gq proteins, leading to mobilization of calcium and activation of MAPK signaling. It is expressed in multiple tissues including the circulatory system, reproductive organs, endocrine and gastrointestinal systems. PROKR1 signaling regulates angiogenesis, trophoblast cell proliferation and adhesion, and immune gene expression, and it has roles in early pregnancy, placentation, and various disease processes.
Modulation (agonists/antagonists) of prokineticin ligand binding, altering G protein signaling—including MAPK and PI3K/AKT pathways—which affects calcium mobilization, angiogenesis, proliferation, and immune gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prokineticin receptor 1 (PROKR1).